Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Measles Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Measles Vaccine are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Measles Vaccine market segmented into
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Based on the end-use, the global Measles Vaccine market classified into
Children
Adults
Based on geography, the global Measles Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MEASLES VACCINE INDUSTRY
2.1 Summary about Measles Vaccine Industry
2.2 Measles Vaccine Market Trends
2.2.1 Measles Vaccine Production & Consumption Trends
2.2.2 Measles Vaccine Demand Structure Trends
2.3 Measles Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
4.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Children
4.3.2 Adults
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
5.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Children
5.3.2 Adults
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
6.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Children
6.3.2 Adults
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
7.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Children
7.3.2 Adults
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
8.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Children
8.3.2 Adults
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
9.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Children
9.3.2 Adults
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 Sanofi-Pasteur
10.1.3 Merck
10.1.4 Novartis
10.1.5 Pfizer
10.1.6 Serum Institute of India
10.1.7 China National Biotech Group
10.1.8 Bavarian Nordic
10.1.9 Emergent Biosolutions
10.1.10 Medimmune
10.1.11 Johnson & Johnson
10.1.12 CSL Limited
10.2 Measles Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 Sanofi-Pasteur
10.2.3 Merck
10.2.4 Novartis
10.2.5 Pfizer
10.2.6 Serum Institute of India
10.2.7 China National Biotech Group
10.2.8 Bavarian Nordic
10.2.9 Emergent Biosolutions
10.2.10 Medimmune
10.2.11 Johnson & Johnson
10.2.12 CSL Limited
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
Table Measles Vaccine Product Type Overview
Table Measles Vaccine Product Type Market Share List
Table Measles Vaccine Product Type of Major Players
Table Brief Introduction of GSK
Table Brief Introduction of Sanofi-Pasteur
Table Brief Introduction of Merck
Table Brief Introduction of Novartis
Table Brief Introduction of Pfizer
Table Brief Introduction of Serum Institute of India
Table Brief Introduction of China National Biotech Group
Table Brief Introduction of Bavarian Nordic
Table Brief Introduction of Emergent Biosolutions
Table Brief Introduction of Medimmune
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of CSL Limited
Table Products & Services of GSK
Table Products & Services of Sanofi-Pasteur
Table Products & Services of Merck
Table Products & Services of Novartis
Table Products & Services of Pfizer
Table Products & Services of Serum Institute of India
Table Products & Services of China National Biotech Group
Table Products & Services of Bavarian Nordic
Table Products & Services of Emergent Biosolutions
Table Products & Services of Medimmune
Table Products & Services of Johnson & Johnson
Table Products & Services of CSL Limited
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Measles Vaccine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Measles Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Measles Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Measles Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Measles Vaccine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Measles Vaccine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Measles Vaccine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Measles Vaccine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Measles Vaccine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Measles Vaccine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Measles Vaccine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Measles Vaccine Sales Revenue (Million USD) of GSK 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Sanofi-Pasteur 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Merck 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Serum Institute of India 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of China National Biotech Group 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Bavarian Nordic 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Emergent Biosolutions 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Medimmune 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Measles Vaccine Sales Revenue (Million USD) of CSL Limited 2017-2020e
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...
Overview of the Global Digital Vaccine Tracking System Market:
The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...